Current antipsychotic agent use and risk of venous thromboembolism and pulmonary embolism: a systematic review and meta-analysis of observational studies
Therapeutic Advances in Psychopharmacology · 2021-01 · 11
DOI: 10.1177/2045125320982720 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 14.01.2021. Verfasst von Yinzhao Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Psychiatry, Nanjing Brain Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu, China. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Talent project of Jiangsu Province, China, Social Development Foundation of Jiangsu Province, China, National Natural Science Foundation of China.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
Antipsychotic agents (APS) are widely used drugs to treat psychotic symptoms and can effectively reduce both positive and negative symptoms of schizophrenia. For decades, some studies suggested that there is a relationship between using APS and the risk of venous thromboembolism (VTE) and pulmonary embolism (PE). However, results remain inconclusive.
Method
This review has been registered in International Prospective Register of Systematic Reviews (PROSPERO, ID: CDR42020155620). Relevant studies were identified among observational studies published up to 1 October 2019 in the databases MEDLINE, EMBASE, and Cochrane Library. Random or fixed-effects models were used to calculate the pooled odds ratio (OR).
Results
In total, 28 observational studies were included. The results showed that compared with non-users, current APS users have significantly increased risks of VTE [OR 1.55 95% confidence interval (CI) 1.36, 1.76] and PE (OR 3.68, 95% CI 1.23, 11.05). Subgroup analyses suggested that new users were associated with a higher risk of VTE (OR 2.06, 95% CI 1.81, 2.35). For individual drugs, increased risk of VTE and PE was observed in taking haloperidol, risperidone, olanzapine, prochlorperazine but not in chlorpromazine, quetiapine or aripiprazole. However, careful interpretation is needed because of high heterogeneity among studies and scarce data.
Conclusion
The present comprehensive meta-analysis further indicates a significantly increased risk of VTE and PE in current APS users compared with non-users. Subgroup analyses suggest that new users are more likely to develop VTE. However, due to significant heterogeneity among studies, conclusions should be considered with caution.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Geriatric Psychiatry, Nanjing Brain Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Cognitive Science, Yale University, New Haven, CT, USA.
- Institute of Neuropsychiatry, the Affiliated Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China.
- Department of Geriatric Psychiatry, Nanjing Brain Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu 210029, China.
- Department of Psychiatry, Huai'an No. 3 People's Hospital, Huai'an 223001, Jiangsu, China.
ORCID-Profile: Yinzhao Liu
Förderung
- Talent project of Jiangsu Province, China
- Social Development Foundation of Jiangsu Province, China
- National Natural Science Foundation of China
- national key research and development program of china
Zitieren
APA
Liu, Y., Xu, J., Fang, K., Xu, Y., Gao, J., Zhou, C., Tang, X., Fang, X., Chen, J., Xie, C., Zhang, F., Zhang, X., & Wang, C. (2021). Current antipsychotic agent use and risk of venous thromboembolism and pulmonary embolism: a systematic review and meta-analysis of observational studies. Therapeutic Advances in Psychopharmacology, 11. https://doi.org/10.1177/2045125320982720
Vancouver
Liu Y, Xu J, Fang K, Xu Y, Gao J, Zhou C, et al. Current antipsychotic agent use and risk of venous thromboembolism and pulmonary embolism: a systematic review and meta-analysis of observational studies. Therapeutic Advances in Psychopharmacology. 2021;11. doi:10.1177/2045125320982720
BibTeX
@article{Liu2021,
author = {Liu, Yinzhao and Xu, Jun and Fang, Kacey and Xu, Yue and Gao, Ju and Zhou, Chao and Tang, Xiaowei and Fang, Xinyu and Chen, Jiu and Xie, Chunming and Zhang, Fuquan and Zhang, Xiangrong and Wang, Congjie},
title = {Current antipsychotic agent use and risk of venous thromboembolism and pulmonary embolism: a systematic review and meta-analysis of observational studies},
journal = {Therapeutic Advances in Psychopharmacology},
year = {2021},
volume = {11},
doi = {10.1177/2045125320982720}
}
EUVIMED